246 related articles for article (PubMed ID: 22180533)
1. E2F7 represses a network of oscillating cell cycle genes to control S-phase progression.
Westendorp B; Mokry M; Groot Koerkamp MJ; Holstege FC; Cuppen E; de Bruin A
Nucleic Acids Res; 2012 Apr; 40(8):3511-23. PubMed ID: 22180533
[TBL] [Abstract][Full Text] [Related]
2. Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression.
Yuan R; Liu Q; Segeren HA; Yuniati L; Guardavaccaro D; Lebbink RJ; Westendorp B; de Bruin A
EMBO J; 2019 Oct; 38(20):e101430. PubMed ID: 31475738
[TBL] [Abstract][Full Text] [Related]
3. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.
Di Stefano L; Jensen MR; Helin K
EMBO J; 2003 Dec; 22(23):6289-98. PubMed ID: 14633988
[TBL] [Abstract][Full Text] [Related]
4. Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.
Christensen J; Cloos P; Toftegaard U; Klinkenberg D; Bracken AP; Trinh E; Heeran M; Di Stefano L; Helin K
Nucleic Acids Res; 2005; 33(17):5458-70. PubMed ID: 16179649
[TBL] [Abstract][Full Text] [Related]
5. Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression.
Liu B; Shats I; Angus SP; Gatza ML; Nevins JR
J Biol Chem; 2013 Aug; 288(34):24581-9. PubMed ID: 23853115
[TBL] [Abstract][Full Text] [Related]
6. DNA-damage response control of E2F7 and E2F8.
Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB
EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719
[TBL] [Abstract][Full Text] [Related]
7. Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression.
Boekhout M; Yuan R; Wondergem AP; Segeren HA; van Liere EA; Awol N; Jansen I; Wolthuis RM; de Bruin A; Westendorp B
EMBO Rep; 2016 Mar; 17(3):414-27. PubMed ID: 26882548
[TBL] [Abstract][Full Text] [Related]
8. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression.
Carvajal LA; Hamard PJ; Tonnessen C; Manfredi JJ
Genes Dev; 2012 Jul; 26(14):1533-45. PubMed ID: 22802528
[TBL] [Abstract][Full Text] [Related]
9. Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.
Thurlings I; Martínez-López LM; Westendorp B; Zijp M; Kuiper R; Tooten P; Kent LN; Leone G; Vos HJ; Burgering B; de Bruin A
Oncogene; 2017 Feb; 36(6):829-839. PubMed ID: 27452520
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.
de Bruin A; Maiti B; Jakoi L; Timmers C; Buerki R; Leone G
J Biol Chem; 2003 Oct; 278(43):42041-9. PubMed ID: 12893818
[TBL] [Abstract][Full Text] [Related]
11. An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability.
Mitxelena J; Apraiz A; Vallejo-Rodríguez J; García-Santisteban I; Fullaondo A; Alvarez-Fernández M; Malumbres M; Zubiaga AM
Nucleic Acids Res; 2018 May; 46(9):4546-4559. PubMed ID: 29590434
[TBL] [Abstract][Full Text] [Related]
12. Protein-DNA interactions at the major and minor promoters of the divergently transcribed dhfr and rep3 genes during the Chinese hamster ovary cell cycle.
Wells J; Held P; Illenye S; Heintz NH
Mol Cell Biol; 1996 Feb; 16(2):634-47. PubMed ID: 8552092
[TBL] [Abstract][Full Text] [Related]
13. Chk1 and 14-3-3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest.
Yuan R; Vos HR; van Es RM; Chen J; Burgering BM; Westendorp B; de Bruin A
EMBO J; 2018 Mar; 37(5):. PubMed ID: 29363506
[TBL] [Abstract][Full Text] [Related]
14. The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence.
Aksoy O; Chicas A; Zeng T; Zhao Z; McCurrach M; Wang X; Lowe SW
Genes Dev; 2012 Jul; 26(14):1546-57. PubMed ID: 22802529
[TBL] [Abstract][Full Text] [Related]
15. Functional interplay between E2F7 and ribosomal rRNA gene transcription regulates protein synthesis.
Coutts AS; Munro S; La Thangue NB
Cell Death Dis; 2018 May; 9(5):577. PubMed ID: 29760477
[TBL] [Abstract][Full Text] [Related]
16. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
[TBL] [Abstract][Full Text] [Related]
17. Atypical E2Fs inhibit tumor angiogenesis.
Weijts BGMW; Westendorp B; Hien BT; Martínez-López LM; Zijp M; Thurlings I; Thomas RE; Schulte-Merker S; Bakker WJ; de Bruin A
Oncogene; 2018 Jan; 37(2):271-276. PubMed ID: 28925392
[TBL] [Abstract][Full Text] [Related]
18. NPAT expression is regulated by E2F and is essential for cell cycle progression.
Gao G; Bracken AP; Burkard K; Pasini D; Classon M; Attwooll C; Sagara M; Imai T; Helin K; Zhao J
Mol Cell Biol; 2003 Apr; 23(8):2821-33. PubMed ID: 12665581
[TBL] [Abstract][Full Text] [Related]
19. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F.
van Wijnen AJ; van Gurp MF; de Ridder MC; Tufarelli C; Last TJ; Birnbaum M; Vaughan PS; Giordano A; Krek W; Neufeld EJ; Stein JL; Stein GS
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11516-21. PubMed ID: 8876167
[TBL] [Abstract][Full Text] [Related]
20. Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.
Li J; Ran C; Li E; Gordon F; Comstock G; Siddiqui H; Cleghorn W; Chen HZ; Kornacker K; Liu CG; Pandit SK; Khanizadeh M; Weinstein M; Leone G; de Bruin A
Dev Cell; 2008 Jan; 14(1):62-75. PubMed ID: 18194653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
